Abrynta Trademark Details

Abrynta was registered on Tuesday, August 20, 2013 and is currently owned by Pfizer Inc. under the registration number 4388555 . This mark is alive with a status of Registered. The last case file activity for this mark occured 10 years ago on Tuesday, August 20, 2013, according to the United State Patent & Trademark Office
Word Mark Abrynta
Status Alive Registered 700 — Registered
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Pfizer Inc.
235 East 42nd Street
New York, Ny 10017
Serial Number 85307100
Registration Number 4388555
Status Date Tuesday, August 20, 2013
Filing Date Tuesday, August 20, 2013
Registration Date Tuesday, August 20, 2013
Attorney Cindy M. Zelson

Correspondent

CINDY M. ZELSON
PFIZER INC.
150 E 42ND ST
NEW YORK, NY 10017-5612

Case File Statements

Goods & Services Vaccines for Human Use

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 006, 018, 044, 046, 051, 052
Status 6 — Active
Status Date Tuesday, May 3, 2011
First Use Anywhere Tuesday, April 30, 2013
First Use In Commerce Tuesday, April 30, 2013
Primary Code 005

You must be signed in to print.

Once signed in, look for the PDF button.